View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Kering: Monthly statement on the total number of shares and voting rig...

Kering: Monthly statement on the total number of shares and voting rights (February 2026)   KeringSociété anonyme with a share capital of €493,683,112Head office: 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARISFebruary 17, 2026 Monthly statement on the total number of shares and voting rights(articles L.233-8 of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers) Date Total number ofsharesTotal number of voting rightstheoretical 1exercisable 2February 15, 2026123,420,778176,675,117175,874,69...

 PRESS RELEASE

Kering : Publication mensuelle du nombre d’actions composant le capita...

Kering : Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote (Février 2026)    KeringSociété anonyme au capital de 493 683 112 €Siège social : 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS  Le 17 février 2026 Publication mensuelle du nombre d’actions composant le capital et du nombre total de droits de vote(articles L. 233-8 du code de commerce et 223-16 du règlement général de l’AMF) Date d’arrêté desinformationsNombre total d’actionscomposant le capitalNombre total de droits de votethéoriques 1exerçables 2 15/02/2026  123 420 77817...

ASML Holding NV: 1 director

A director at ASML Holding NV bought 254 shares at 1,180.020EUR and the significance rating of the trade was 87/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...

 PRESS RELEASE

ASML reports transactions under its current share buyback program

ASML reports transactions under its current share buyback program ASML reports transactions under its current share buyback program VELDHOVEN, the Netherlands – ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. DateTotal repurchased sharesWeighted average priceTotal repurchased value09-Feb-2620,923€1,192.93€24,959,62010-Feb-2620,847€1,201.12€25,039,73011-Feb-2620,877€1,197.41€24,998,35212-Feb-2620,699€1,207.88€25,001,87713-Feb-2622,454€1,194.06€26,811,446 ASML’s current share buyback program was announced on 28 January 2026, ...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Aedifica: Conference call highlights. Basic-Fit: Belgian VAT increase for culture, sports and takeaway meals postponed. BE Semiconductor Industries: 4Q25 Preview, incremental strength. Kendrion: Preview - Clean into 2026. Magnum Ice Cream Company: Acquisition of Kwality Wall's launched. Retail Estates: Re-letting progress highlights portfolio quality. Semi Equipment: AMAT readthrough strength. Universal Music Group: EU Commission approves UMG's Downtown acquisition, requires full Curve Ro...

Research Department
  • Research Department

IBERIAN DAILY 16 FEBRUARY + 4Q’25 RESULTS. HIGHLIGHTS AND REST OF PREV...

NEWS SUMMARY: ACS, GREENING, INDRA, REPSOL. At the end of today’s report, and during the entire results season, we will include a presentation with positive and negative results highlights and previews for the 4Q’25 results to be released over the coming days in Spain. Doubts continue European stock markets saw a mixed performance, with core markets faring better vs. the weakness of the peripheral segment where the Ibex questioned again the 17,700 support level. In the STOXX 600, the best-perf...

Research Department
  • Research Department

INFORME DIARIO 16 FEBRERO + RDOS. ESPAÑA Y EUROPA. IDEAS DESTACADAS Y ...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: ACS, GREENING, INDRA, REPSOL. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Un mercado con muchas dudas Disparidad en las bolsas europeas, con un desempeño más sólido de los mercados core frente a la debilidad de la periferia, donde el Ibex...

Arancha Pineiro
  • Arancha Pineiro
Research Department
  • Research Department

INFORME DIARIO 13 FEBRERO + RDOS. ESPAÑA. IDEAS DESTACADAS Y PREVIEWS ...

COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: REPSOL, TELEFÓNICA. EUROPA: HERMÈS INT., L’ORÉAL, SAFRAN. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’25 que se publicarán en España y Europa en los próximos días. Siguen las dudas sobre la rentabilidad de la IA Las bolsas europeas revertieron las ganancias en el tramo final de la sesión, presionadas...

 PRESS RELEASE

Résultats annuels 2025

Résultats annuels 2025 CROISSANCE SOLIDE, MARGES RENFORCÉESACCÉLÉRATION CONFIRMÉE Chiffre d'affaires : 44,05 milliards d’euros, + 4,0 % à données comparables1 et + 1,3 % à données publiées.Nouvelle année de surperformance dans un marché de la beauté qui s’améliore.Croissance1 dans toutes les Divisions, portée par les Produits Professionnels.Croissance1 dans toutes les Zones, avec une accélération globale au second semestre.Le E-commerce2croit à deux chiffres et franchit la barre des 30 %.Marge brute en hausse de + 10 points de base à 74,3 %.Marge d'exploitation en hausse de + 20 points d...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch